The pathway of de novo biosynthesis of the four essential pyrimidine nucleoside triphosphates by enteric bacteria is now well established ( Fig. 1 ), but the routes by which they are able to utilize exogenously supplied pyrimidine bases and nucleosides are only partially understood (19) . These auxiliary or salvage pathways are quite extensive. Some years ago it was established that each of the six pyrimidine bases and nucleosides were equally effective as precursors of the pyrimidine moieties of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) (6, 14) , and it is further known that each of the six bases and nucleosides is able to meet the total pyrimidine demands of a pyrimidine auxotroph.
Elucidation of the pyrimidine salvage pathways, in addition to adding to our general knowledge of the metabolism of enteric bacteria, is important from several points of view.
Such knowledge is essential to the intelligent selection and use of radioactive compounds for the labeling of nucleic acids and their precursors; it provides a basis for understanding the mechanism of action of pyrimidine analogues, and for isolating mutants (often by positive selection techniques) blocked in the various steps of the salvage pathways.
Previously we have reported the chromosomal location of a number of genes encoding enzymes of the salvage pathway (5) . In this paper, by using mutant strains, we establish the various pathways by which the six pyrimidine bases and nucleosides are metabolized by Salmonella typhimurium.
I Permanent address: Enzyme Division, University Institute of Biological Chemistry B, Copenhagen K, Denmark. MATERIALS AND METHODS Media. The 007 medium (7) was used as a basal salts medium. Glucose was added to 0.1%. Amino acid supplements were added at a final concentration of 50 Ag/ml; and pyrimidines at the following concentrations: uracil and cytosine, 20 ;g/ml; uridine and cytidine, 40 ;g/ml; thymine and thymidine, 20 ,ug/ml. Plates in which cytidine or cytosine was the total source of nitrogen contained the normal minimal salts medium without inorganic nitrogen but with cytidine or cytosine added at 200 ,ug/ml. In media in which nucleosides were the total carbon source, glucose was replaced with the nucleoside at 500 jg/ml. Nutrient broth (Difco) was used as an enriched medium. When nucleoside-requiring strains were grown in enriched medium, the nucleoside was added at 40 jig/ml. Mutagenesis and genetics. Mutagenesis employed N-methyl-N-nitroso-N'-nitroguanidine (1) . The procedures for penicillin counterselection (25) and for genetic manipulation (5) were as previously described.
Bacterial strains. S. typhimurium, strain LT2, was the original parent of all strains used in these experiments. Table 1 lists the strains used and their genotypes. Table 2 lists the selections used for individual mutations. Table 3 verifies the genotypes.
Preparation of enzyme extracts. Cells were grown ovemight in 250-ml batches of glucose minimal media containing 0.15% norite-treated, vitamin-free casein hydrolysate (Nutritional Biochemical Corp.) and 50 ug of uridine and cytidine/ml. Uridine and cytidine were not included in cultures grown for assays of cytosine deaminase (cod) and thymidine kinase (tdk). Cells were harvested by centrifugation, washed once in 0.9% NaCl, resuspended in 5 ml of buffer, and sonically treated three times for 20 sec with a Biosonic oscillator. Extracts were centrifuged for 15 min at 17,000 x g at 3 C, and the supernatant liquid was treated with one-fifth volume of 10% streptomycin sulfate. After centrifugation (15 min at 17,000 x g) the extract was dialyzed for 2 hr For each enzyme the same buffer was used during in the cases of cytosine deaminase, thymidine ki-sonic treatment, dialysis, and assay. The following nase, and uridine kinase, and overnight in the cases buffers were used: (i) for cytidine deaminase, uridine of cytidine deaminase, uridine phosphorylase, and phosphorylase, and UMP pyrophosphorylase: 0 pyrCl5O2,cdd-9,cod-8,tpp-1,udp-11,argB69 b Genetic designation udc indicates the phenotype of complete inability to utilize uridine as pyrimidine source in a udp-background.
c Strain selected in two steps: a thy mutation was introduced by resistance to trimethoprim (24) and then replaced with argB69 by cotransduction. ride at pH 7.3, 10 mm MgCl2, and 2 mm 2-mercaptoethanol; (ii) for cytosine deaminase: 0.05 M Trishydrochloride at pH 7.3; (iii) for uridine kinase and thymidine kinase: 0.1 M Tris-hydrochloride at pH 7.8, 10 mM MgCl2, and 2 mM 2-mercaptoethanol. Cytidine deaminase (cdd). Assay was made in a 0.5-ml reaction mixture containing 0.05 M Tris-hydrochloride at pH 7.3, 10 mM MgCl2, 2 mm 2-mercaptoethanol, 1 mm cytidine (or 2'-deoxycytidine), and enzyme. The reaction mixture was incubated at 37 C, and at appropriate times 0.1-ml samples were taken into 0.9 ml of ice-cold 0.5 M perchloric acid. The precipitated protein was removed by centrifugation, and absorbancy of the supematant fluid was determined at 290 nm. A difference of absorbancy of 1.01 (1-cm light path) is equivalent to a change in substrate concentration of 0.1 mM.
Cytosine deaminase (cod). Assays were made in 0.5 ml of reaction mixture containing: 0.05 M Trishydrochloride at pH 7.3, 1.0 mM cytosine, and enzyme. The reaction mixture was incubated at 37 C, and at appropriate times 0.1-ml samples were taken into 0.9 ml of ice-cold 0.5 M perchloric acid. The precipitated protein was removed by centrifugation, and absorbancy of the supernatant fluid was read at 282 nm. A difference of absorbancy of 0.73 (1-cm light path) is equivalent to a change in substrate concentration of 0.1 mm.
Thymidine kinase (tdk). Assays were made in 50 Aliters of reaction mixture containing: 0.1 M Trishydrochloride at pH 7.8, 10 mM MgCl2, 2 mM 2-mercaptoethanol, 3 mm adenosine triphosphate (ATP), 1 mm thymidine-2-14C (1 mCi/mmole), 1 mM KCl, and enzyme. The reaction mixture was incubated at 37 C and at appropriate times, 10 lAiters of reaction mixture was spotted on thin-layer plates coated with poly(ethylene imine)-cellulose (PEI) (21) , and dried with hot air to stop the reaction. Plates were washed with methanol, dried, and developed stepwise in methanol (3 cm) and water (10 cm) . The areas where the samples were applied to the plates (containing the phosphorylated products) were cut out and counted in a Packard Tricarb liquid scintillation spectrometer in vials containing 7 ml of toluene base scintillation mixture.
Uridine kinase (udk). Assay was based on observations of L. Finch (personal communication) who suggested the use of guanosine triphosphate (GTP).
Assays were made in 50 gliters of reaction mixture containing: 0.1 M Tris-hydrochloride at pH 7.8, 10 mM MgCl2, 2 mM 2-mercaptoethanol, 3 mM GTP, 1 mM [2-4C] nucleoside (uridine or cytidine at 1 mCi/mmole), 1 mm KCl. Reaction mixture was incubated at 37 C, and at 20 min a 25-gliter sample was taken and spotted to PEI-cellulose thin-layer plates and processed as described for thymidine kinase.
Uridine phosphorylase (udp). Assays were made in 1.0 ml of reaction mixture containing: 0 acil can be seen by comparing the growth responses of strains JL1215 and KP1091 (Table  4) . The strains differ with respect to uracil metabolism; JL1215 carries a mutation, upp-17, which renders UMP pyrophosphorylase nonfunctional, whereas KP1091 carries a wildtype allele of the gene. At 42 C, uracil satisfies the pyrimidine requirement of KP1091 but not of JL1215. Thus UMP pyrophosphorylase is essential for the utilization of exogenous uracil; the route through uridine phosphorylase (udp) and uridine kinase (udk) does not function biosynthetically.
By comparing the effect of analogues on the growth of these two strains at 30 C (Table 4) , we can further conclude that the pyrimidine analogue 5-fluorouracil (FU) is incorporated into the nucleotide pool by the same route as uracil. FU exerts its toxicity by being converted into 5-fluorouracil triphosphate (FUTP) (12) , which, in turn, is incorporated into RNA rendering it nonfunctional. Strain JL1215, which lacks UMP pyrophosphorylase, is completely resistant to FU; strain KP1091 which contains it is sensitive.
Cytosine metabolism. Previously we have shown (18) that mutant strains which are unable to synthesize cytidine triphosphate (CTP) owing to a genetic block in the conversion of UTP to CTP (pyrG) require exogenous cytidine for growth; the requirement, however, cannot be met by exogenous cytosine, i.e. S. typhimurium is incapable of converting cytosine to either cytidine or cytidine monophosphate (CMP). We concluded from these results that the only route by which cytosine is utilized is through deamination by cytosine deaminase (EC 3.5.4.1; cytosine aminohydrolase) to yield uracil. Hence, one would predict that a pyrimidine auxotroph lacking cytosine deaminase could not have its pyrimidine requirement met by cytosine. A comparison of strains JL1019 and KP1077 (Table 4) establishes the validity of this prediction.
The mutation cod-5 also confers resistance to the analogue 5-fluorocytosine (FC) but not to FU at 30 C, so we can conclude that FC is metabolized by the same route as cytosine, namely, it is only converted to FU.
The enzyme is capable of deaminating cytosine at a sufficiently rapid rate to allow maximal growth rates when cytosine supplies the total pyrimidine demands of the cell, but unlike Escherichia coli (Jan Neuhard, unpublished data) our S. typhimurium LT-2 strains cannot use cytosine as a total nitrogen source.
Deoxycytidine metabolism. Enteric bacteria have been shown to lack a deoxycytidine kinase (13, 17) , and hence this deoxynucleoside is unable to serve as a direct source of cytosine deoxyribonucleotides. Both E. coli and S. typhimurium contain an inducible cytidine deaminase (EC 3.5.4.5; cytidine aminohydrolase) for which deoxycytidine (CdR) appears to be the preferred substrate (26) and will use deoxycytidine as a total source of pyrimidine. Our data establish that the deamination of CdR to deoxyuridine (UdR) is the essential first step in the utilization of CdR as a pyrimidine source. Strain KP1074 which carries a mutation (cdd-9) encoding an inactive cytidine deaminase is unable to use CdR but can use UdR as a total pyrimidine source; JL1019 which produces an active cytidine deaminase can utilize both CdR and UdR as a total source of pyrimidine (Table 4) . Strain KP1074, but not JL1019, is resistant to the analogue 5-fluoro-2'-deoxycytidine (FCdR) but is sensitive to 5-fluoro-2'-deoxyuridine (FUdR). Hence we can conclude that for FCdR to be toxic it must first be converted to FUdR and, further, that this conversion is catalyzed by cytidine deaminase.
The deamination of CdR by cytidine deaminase is sufficiently rapid to meet the total nitrogen requirements of the cell from the ammonia produced by the reaction.
Deoxyuridine metabolism. UdR is known to undergo two reactions in enteric bacteria; the enzyme, thymidine kinase (tdk) (EC 2.7.1.21; ATP: thymidine 5'-phosphotransferase), is capable of phosphorylating UdR [as well as deoxythymidine (TdR)] to form dUMP (20) , and the inducible enzyme, thymidine phosphorylase (tpp) (EC 2.4.2.4; thymidine: orthophosphate deoxyribosyltransferase), splits UdR (as well as TdR) to form uracil and deoxyribose-1-phosphate. Via the latter reaction, UdR may serve as a total source of pyrimidine (through formation of uracil) and as a total source of carbon and energy (through formation of deoxyribose-1-phosphate).
UdR serves as a total source of carbon and energy only if the cell contains an active thymidine phosphorylase (9). We note from Table  4 that strain KP1091 can grow on UdR as a sole source of carbon and energy, whereas strain KP1124, which lacks thymidine phosphorylase (tpp-1), is unable to grow on UdR as a carbon source. We further notice that KP1124 retains its ability to utilize UdR as a pyrimidine source. In confirmation of the recent results of Beacham and Pritchard (4) with E. coli, we found that the residual ability of tpp-strains to utilize UdR as a pyrimidine source is dependent on the activity of the en- zyme uridine phosphorylase (udp) which apparently has activity for the alternate substrate, UdR. JL1193 which lacks both thymidine and uridine phosphorylases cannot utilize UdR either as a source of carbon or as a source of pyrimidine (Table 4) . By comparing the responses of strains blocked in the reactions catalyzed by uridine and thymidine phosphorylases we can further conclude that the UdR analogue, FUdR, exerts its toxicity by two different biochemical mechanisms. (i) It is split to yield FU; (ii) it is phosphorylated to FdUMP which is a competitive inhibitor of thymidylate synthetase (8) and thus causes thymine starvation. Resistance to the former route of toxicity can be obtained by blocking the breakdown of FUdR to FU (introducing mutations in tpp and udp) or alternatively preventing the reutilization of FU (introducing a mutation in upp or adding uracil to the medium which effectively competes with FU and prevents its conversion to FUMP). Starting with a strain (JL1193; tpp-1, udp-11) which lacks the first route leading to FUdR toxicity, we have been able to isolate a strain (JL1221) which is completely resistant to FUdR owing to an additional mutation in the gene encoding thymidine kinase (tdk-1).
Subsequently we have found that it is not necessary to block both uridine and thymidine phosphorylases in order to isolate mutants in tdk by resistance to FUdR. Such mutants can be isolated directly in strains producing normal uridine phosphorylase simply by adding exogenous uracil which antagonizes the FU generated by phosphorolytic cleavage of FUdR. However, a block in thymidine phosphorylase is required for this selection even in the presence of exogenous uracil, probably because tpp+ strains phosphorolyze FUdR too rapidly to maintain toxic intracellular concentrations of the analogue.
Uridine metabolism. Uridine (UR) undergoes two known reactions in enteric bacteria. It is converted to UMP by uridine kinase (3) (EC 2.7.1.48; ATP: uridine 5'-phosphotransferase) and to uracil (U) (22) by the inducible uridine phosphorylase (11) . Thus there are two routes by which uridine can give rise to uridine triphosphate (UTP) through UMP: (i) by direct conversion to UMP through the action of uridine kinase; or (ii) by phosphorolysis to yield uracil and subsequent conversion to UMP (UMP pyrophosphorylase). Both of these routes function in vivo. Pyrimidine auxotrophs which lack the first route owing to genetic blocks in udk, the gene encoding uridine kinase, can utilize uridine by the second route to satisfy their requirement for pyrimidine (see strain JL1208, Table 4 ). Alternatively, strains which are blocked in the second route owing to mutations in genes encoding uridine phosphorylase (udp), UMP pyrophosphorylase (upp), or both, are able to use the first route to supply their pyrimidine requirements (Table 4 , strains KP1119, JL1215, and KP1146, respectively). If both routes are blocked by introducing negative mutations in udk, udp, and upp, the strain is unable to use uridine as a pyrimidine source, as is strain KP1130 (Table 4) .
Having established that two routes for UTP biosynthesis from UR are operative in vivo in S. typhimurium, we are in a position to determine the distribution of flow between these two possible routes. We have done this by studying the growth yield from uridine of various mutants (Fig. 2) . Strains which lack UMP pyrophosphorylase (upp) are unable to reutilize uracil which is derived from UR by uridine phosphorylase, and hence, in these strains the UR-to-U-to-UMP route does not contribute to the growth yield. The growth yield, therefore, is a direct measurement of the flow through the UR to UMP route. strain KP1091 (udk+, udp+, upp+) is a measure of the total utilization of UR (100%). Strain JL1215 carries a mutation in UMP pyrophosphorylase (upp-17) thus precluding the reutilization of uracil. We notice (Fig. 2) that the growth yield of JL1215 from UR is only about 25% of that of KP1091, and we conclude that under these conditions 75% of uridine added is broken down to uracil; i.e., the major route of utilization of UR is through uracil. Blocking the breakdown of UR by introducing a mutation in udp (strain KP1125) might be expected to return the growth yield on UR to 100%. But such is not the case (Fig. 2) We have found that cytidine and uridine kinases are a single protein encoded by a single gene (udk). Two observations lead to this conclusion. (i) Strains carrying mutations in udk are resistant not only to FUR but also to the cytidine analogue 5-fluorocytidine (FCR). (ii) Strains carrying mutations in udk lack both uridine and cytidine kinase activities (Table 3) .
One might predict that a pyrimidine auxotroph which lacks cytidine deaminase (cdd) would have its pyrimidine requirement only partially satisfied by cytidine; i.e., that cytidine could satisfy the requirement for cytosine nucleotides but not for uracil nucleotides. But such is not the case. KP1074 (pyrC1502, cdd-9) can utilize cytidine as a total source of pyrimidine (Table 4) . Clearly, therefore, there is a route from CR to uracil nucleotides which does not go through cytidine deaminase; i.e., there is a second CR-to-UMP route. We can ask if cytosine is an intermediate of this route and the answer is no, because we know (see Cytosine metabolism section) that the only route of metabolism of cytosine is by way of cytosine deaminase (cod), and strains lacking both cytidine and cytosine deaminases are still capable of using cytidine as a total source of pyrimidine (compare strains KP1091 and KP1074, Table 4 ). The possibility of deamination at the nucleotide level is eliminated by the finding ( Table 4 ) that strains carrying mutations in cdd, cod, and udk (JL1208) are able to utilize cytidine as a total source of pyrimidine. Thus, direct deamination of CR to UR appears to be the only remaining possibility, and we have established that the route, in fact, flows through UR because strain JL1210 (cdd, udp, udc, udk), which is unable to grow on UR, is also unable to grow on CR as a total pyrimidine source (Table 4) . Surprisingly, strains lacking both cytidine deaminase and UMP pyrophosphorylase cannot have their entire pyrimidine requirement satisfied by CR (strain JL1215, Table 4 ). Thus even in a strain lacking cytidine deaminase the route must be: CR --UR d U -UMP. It is reasonable to ask why uridine kinase is not capable of directly converting UR to UMP under these conditions. An explanation might be that CR, when present in excess, competes effectively with UR for uridine kinase and thereby prevents the direct conversion of UR to UMP. In fact we have shown that the growth of the JL1125 (upp, cdd) pyrimidine auxotroph on UR is inhibited by CR. The enzyme which deaminates CR in strains lacking cytidine deaminase remains unknown.
Conclusions. (i) The routes by which exogenous pyrimidine bases and nucleosides are metabolized are summarized in Fig. 1 .
(ii) Certain enzymes catalyze two reactions as shown in Fig. 1 . Uridine kinase phosphorylates both uridine and cytidine. Thymidine kinase phosphorylates both thymidine and deoxyuridine. Thymidine phosphorylase splits both thymidine and deoxyuridine. Cytidine deaminase deaminates both cytidine and deoxyctidine.
(iii) Certain steps shown in Fig. 1 can be catalyzed by two enzymes. Deoxyuridine is split by thymidine phosphorylase and to a lesser extent by uridine phosphorylase. Uridine can be phosphorolytically cleaved by uridine phosphorylase and can be split by some other unknown activity. Cytidine is converted to uridine by cytidine deaminase and by another unknown activity.
(iv) Exogenously added uridine is mainly broken down to uracil before being incorporated into UTP, and hence radioactive uridine is an unnecessarily complicated label and should be avoided in critical experiments.
(v) The 5-fluoro analogues FU, FC, FUR, FCR, FUdR, and FCdR are metabolized by the same enzymes which metabolize U, C, UR, CR, UdR, and CdR, respectively. The 5-fluoro analogues are toxic only after having been converted to nucleotides.
(vi) FUdR exerts its toxic effect as a consequence of two biochemical routes: by being converted to FdLJMP and by being converted to FU.
(vii) The 5-fluoro analogues can be used to select positively for a number of mutations in genes governing pyrimidine metabolism (see Table 2 ).
(viii) Although the conclusions presented here concern S. typhimurium, cumulative evidence indicates they also apply to E. coli with only slight quantitative differences. Similar studies on utilization of exogenous pyrimidine by Saccharomyces cerevisiae have been made by Grenson (10) .
